| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.0072 | 0.9 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.0084 | 0.9 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.009 | 0.9 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.009 | 0.9 |